Latest news
Like humans, some primates become cautious of germs in the wake of a viral outbreak
Researchers found that macaque monkeys who had lived through a deadly disease outbreak became significantly more cautious about food that appeared contaminated, even though they did not know how the disease had spread. The findings suggest that pathogen-avoidance behavior can be shaped by experience, offering clues about the evolutionary roots of disgust.
Spouses mattered more than genes for the risk of severe COVID-19
Researchers ound no evidence that genetic factors played an important role in determining who was hospitalised with COVID-19. Instead, spouses of hospitalised individuals had more than three times the risk of being hospitalised themselves compared with matched controls.
Vaccination has little impact on post-COVID smell and taste issues
Researchers examining whether COVID-19 vaccination affects persistent smell or taste problems after contracting the virus have found that, in most cases, it does not.
Can better gut health help patients with ovarian cancer tolerate chemotherapy?
A new clinical trial is testing whether probiotics can help patients with ovarian cancer better tolerate chemotherapy. The trial will look at whether probiotics can help reduce treatment side effects and improve quality of life. Researchers will also study how changes in the gut microbiome may be linked to treatment response.
Scientific triumph, equity failure: Faster, fairer COVID-19 vaccine roll-out could have saved millions of lives
Beginning the global COVID-19 vaccine roll-out 100 days after the virus was sequenced could have saved more than 8 million lives by the end of 2021, most of them in lower-middle-income countries. The authors of a new Policy Brief argue that fair vaccine-sharing rules should be established before the next pandemic, rather than negotiated during the crisis itself.
U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently
A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.
Like humans, some primates become cautious of germs in the wake of a viral outbreak
Researchers found that macaque monkeys who had lived through a deadly disease outbreak became significantly more cautious about food that appeared contaminated, even though they did not know how the disease had spread. The findings suggest that pathogen-avoidance behavior can be shaped by experience, offering clues about the evolutionary roots of disgust.
Spouses mattered more than genes for the risk of severe COVID-19
Researchers ound no evidence that genetic factors played an important role in determining who was hospitalised with COVID-19. Instead, spouses of hospitalised individuals had more than three times the risk of being hospitalised themselves compared with matched controls.
Vaccination has little impact on post-COVID smell and taste issues
Researchers examining whether COVID-19 vaccination affects persistent smell or taste problems after contracting the virus have found that, in most cases, it does not.
Perpetual Next signs agreement to accelerate the roll-out of standardized biomethanol plants
Perpetual Next have signed a License and Engineering Agreement with Air Liquide Engineering and Technologies for the supply of syngas-to-methanol technology for Perpetual Next’s first biomethanol facility, with an option to extend across other biomethanol sites.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
Sharpening an essential tool for biotechnology
Scientists develop a database of validated guide RNAs to improve engineering of microbes for manufacturing applications.
Plasmonic coating on bacterial surfaces paves the way for rapid sepsis diagnosis
Researchers have developed a label-free surface-enhanced Raman scattering (SERS) analysis technology that rapidly detects extremely low concentrations of viable bacteria by directly growing plasmonic metal nanostructures on and around bacterial cells.
New platform reveals broad viral exposure histories in pigs
Pigs can retain antibody traces of past viral encounters, yet conventional tests usually examine only a limited number of viruses at a time. Researchers have developed a platform that uses 36,416 short protein fragments from 140 swine-associated viruses to screen many antibody responses in parallel.
One-step rapid syphilis test detects infection earlier, researchers report
A new rapid test detects lower levels of the two types of antibodies the body makes to fight syphilis bacteria and respond to disease-related cell damage, potentially leading to earlier interventions and fewer appointments for patients.
Can better gut health help patients with ovarian cancer tolerate chemotherapy?
A new clinical trial is testing whether probiotics can help patients with ovarian cancer better tolerate chemotherapy. The trial will look at whether probiotics can help reduce treatment side effects and improve quality of life. Researchers will also study how changes in the gut microbiome may be linked to treatment response.
U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently
A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.
Bay Area Lyme Foundation issues call-for-applications for 2027 Emerging Leader Awards and Research Grants
Bay Area Lyme Foundation has announced the opening of applications for the 2027 Emerging Leader Awards (ELA), which recognize researchers identifying innovative approaches to solve the challenges of Lyme and tick-borne illnesses.